Fiona J. Sorrell

Fiona J. Sorrell

Auto-generated profile, based on publicly available information

Fiona J. Sorrell

Department of Chemistry, University of Sheffield, Brook Hill, Sheffield, S7 3HF (UK), Fax: (+44) 114-2229346

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Free Radical Biology and Medicine
Verified
Journal Article
Open access
PCPeter Canning
Peter Canning
FSFiona J. Sorrell
Fiona J. Sorrell
ABAlex Bullock
Alex Bullock
Keap1 is a highly redox-sensitive member of the BTB-Kelch family that assembles with the Cul3 protein to form a Cullin-RING E3 ligase complex for the degradation of Nrf2. Oxidative stress disables Keap1, allowing Nrf2 protein levels to accumulate for the transactivation of critical stress response genes. Consequently, the Keap1-Nrf2 system is extensively pursued for the development of protein-protein interaction inhibitors that will stabilize Nrf2 for therapeutic effect in conditions of neurodegeneration, inflammation, and cancer. Here we review current progress toward the structure determination of Keap1 and its protein complexes with Cul3, Nrf2 substrate, and small-molecule antagonists. Together the available structures establish a rational three-dimensional model to explain the two-site binding of Nrf2 as well as its efficient ubiquitination.

1 March 2016 in Structure
Verified
Journal Article
Open access
FSFiona J. Sorrell
Fiona J. Sorrell
MSMarta Szklarz
Marta Szklarz
KAKamal R. Abdul Azeez
Kamal R. Abdul Azeez
JEJon M. Elkins
Jon M. Elkins
SKStefan Knapp
Stefan Knapp
The highly diverse Numb-associated kinase (NAK) family has been linked to broad cellular functions including receptor-mediated endocytosis, Notch pathway modulation, osteoblast differentiation, and dendrite morphogenesis. Consequently, NAK kinases play a key role in a diverse range of diseases from Parkinson's and prostate cancer to HIV. Due to the plasticity of this kinase family, NAK kinases are often inhibited by approved or investigational drugs and have been associated with side effects, but they are also potential drug targets. The presence of cysteine residues in some NAK family members provides the possibility for selective targeting via covalent inhibition. Here we report the first high-resolution structures of kinases AAK1 and BIKE in complex with two drug candidates. The presented data allow a comprehensive structural characterization of the NAK kinase family and provide the basis for rational design of selective NAK inhibitors.

1 November 2017 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
DPDaniel M. Pinkas
Daniel M. Pinkas
CSCaroline E. Sanvitale
Caroline E. Sanvitale
JBJoshua C. Bufton
Joshua C. Bufton
FSFiona J. Sorrell
Fiona J. Sorrell
NSNicolae Solcan
Nicolae Solcan
ABAlex Bullock
Alex Bullock
Members of the potassium channel tetramerization domain (KCTD) family are soluble non-channel proteins that commonly function as Cullin3 (Cul3)-dependent E3 ligases. Solution studies of the N-terminal BTB domain have suggested that some KCTD family members may tetramerize similarly to the homologous tetramerization domain (T1) of the voltage-gated potassium (Kv) channels. However, available structures of KCTD1, KCTD5 and KCTD9 have demonstrated instead pentameric assemblies. To explore other phylogenetic clades within the KCTD family, we determined the crystal structures of the BTB domains of a further five human KCTD proteins revealing a rich variety of oligomerization architectures, including monomer (SHKBP1), a novel two-fold symmetric tetramer (KCTD10 and KCTD13), open pentamer (KCTD16) and closed pentamer (KCTD17). While these diverse geometries were confirmed by small-angle X-ray scattering (SAXS), only the pentameric forms were stable upon size-exclusion chromatography. With the exception of KCTD16, all proteins bound to Cul3 and were observed to reassemble in solution as 5 : 5 heterodecamers. SAXS data and structural modelling indicate that Cul3 may stabilize closed BTB pentamers by binding across their BTB–BTB interfaces. These extra interactions likely also allow KCTD proteins to bind Cul3 without the expected 3-box motif. Overall, these studies reveal the KCTD family BTB domain to be a highly versatile scaffold compatible with a range of oligomeric assemblies and geometries. This observed interface plasticity may support functional changes in regulation of this unusual E3 ligase family.

13 May 2014 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
FSFrances-Rose Schumacher
Frances-Rose Schumacher
FSFiona J. Sorrell
Fiona J. Sorrell
DADario R. Alessi
Dario R. Alessi
ABAlex Bullock
Alex Bullock
TKThimo Kurz
Thimo Kurz
WNK1 [with no lysine (K)] and WNK4 regulate blood pressure by controlling the activity of ion co-transporters in the kidney. Groundbreaking work has revealed that the ubiquitylation and hence levels of WNK isoforms are controlled by a Cullin-RING E3 ubiquitin ligase complex (CRL3KLHL3) that utilizes CUL3 (Cullin3) and its substrate adaptor, KLHL3 (Kelch-like protein 3). Loss-of-function mutations in either CUL3 or KLHL3 cause the hereditary high blood pressure disease Gordon's syndrome by stabilizing WNK isoforms. KLHL3 binds to a highly conserved degron motif located within the C-terminal non-catalytic domain of WNK isoforms. This interaction is essential for ubiquitylation by CRL3KLHL3 and disease-causing mutations in WNK4 and KLHL3 exert their effects on blood pressure by disrupting this interaction. In the present study, we report on the crystal structure of the KLHL3 Kelch domain in complex with the WNK4 degron motif. This reveals an intricate web of interactions between conserved residues on the surface of the Kelch domain β-propeller and the WNK4 degron motif. Importantly, many of the disease-causing mutations inhibit binding by disrupting critical interface contacts. We also present the structure of the WNK4 degron motif in complex with KLHL2 that has also been reported to bind WNK4. This confirms that KLHL2 interacts with WNK kinases in a similar manner to KLHL3, but strikingly different to how another KLHL protein, KEAP1 (Kelch-like enoyl-CoA hydratase-associated protein 1), binds to its substrate NRF2 (nuclear factor-erythroid 2-related factor 2). The present study provides further insights into how Kelch-like adaptor proteins recognize their substrates and provides a structural basis for how mutations in WNK4 and KLHL3 lead to hypertension.

28 February 2023 in ChemMedChem
Verified
Journal Article
Closed access
JKJohannes Krieger
Johannes Krieger
FSFiona J. Sorrell
Fiona J. Sorrell
AWAnsgar A. Wegener
Ansgar A. Wegener
BLBirgitta Leuthner
Birgitta Leuthner
FMFouzia Machrouhi‐Porcher
Fouzia Machrouhi‐Porcher
SSSarah Schlesiger
Sarah Schlesiger

7 November 2014 in ChemBioChem
Verified
Journal Article
Open access
PDF file
TWTheis S. Wilbek
Theis S. Wilbek
TSTine Skovgaard
Tine Skovgaard
FSFiona J. Sorrell
Fiona J. Sorrell
SKStefan Knapp
Stefan Knapp
JBJens Berthelsen
Jens Berthelsen
KSKristian Strømgaard
Kristian Strømgaard
A novel imidazo-pyramidazine inhibitor of DAPK1 that undergoes class-specific interactions and extends into the substrate recognition site has been identified. This inhibitor is a good starting point for the development of selective and potent inhibitors of DAPK1, with potential use against stroke and ischemia.